+关注
白马非马123
暂无个人介绍
IP属地:河北
44
关注
0
粉丝
2
主题
0
勋章
主贴
热门
白马非马123
2025-12-27
这篇文章不错,转发给大家看看
@等也是一种策略 如何等在哪里等:美国最大独立投行Jefferies也发了2026展望和荐股 主题是:牛市扩散与人工智能的应用阶段。荐股分4个板块: 互联网 $APP:2026年上半年广告平台大幅扩张,目标市值860亿美元 $UBER:机器人出租车合作势头向好+人口结构扩张 $SPOT:新层级业务推动利润率提升;强劲的定价能力 $RDDT:数据授权增长+用户互动加速 $ROKU:业绩反转标的;广告散射市场改善 $Z:房地产市场复苏标的;软件服务业务增长 软件 $NOW:头号标的:最“安全”的人工智能应用标的;生成式人工智能产品套件走向成熟 $SHOP:企业级应用超出预期;业绩实现增长 $TWLO:语音人工智能周期推动增长重回稳定 $HUBS:中小企业人工智能应用龙头;定价能力回归 生物科技 $DNTH:头号标的:神经肌肉疾病III期数据关键节点 $TSHA:雷特综合征基因疗法;关键监管更新 $TYRA:注射剂的口腔替代方案;同类最佳的临床数据输出 $TNG:精准肿瘤学管线走向成熟 $SLDB:杜氏肌营养不良症基因疗法更新 $ORIC:2026年上半年有望迎来肿瘤学催化剂 量子科技 $IONQ:全新赛道:纯量子算力龙头;订单积压充足 $QBTS:商用退火量子计算应用关注度提升 矿业 $FCX:铜供应紧张,满足数据中心需求增长 $GLEN:估值与同行存在偏差;资本回报故事具备吸引力 核心战略要点 1. 轮动策略:超配互联网和软件应用板块,而非纯基础设施(芯片)板块 2. 生物科技复苏:聚焦2026年有临床数据的企业 3. 量子飞跃:2026年被认定为商用量子计算的突破之年
白马非马123
2025-12-11
$科济药业-B(02171)$
白马非马123
2025-12-07
本来很早很早就下载了老虎,但一直没有迈开第一步,直到2025走出了第一步,今年的收入大概百分之八十,边做边学习,我是那种喜欢买了就不急长期拿着的,曾经在大一次一次让我失望。在这里终于找到了适合我的操作方式的市场,很感恩老虎,让我明白平台的重要性。对于2026年我的期望是有百分之十就可以,拿好自己看好的公司。祝大家新的一年都好运连连,也祝老虎越办越好。
白马非马123
2025-10-07
说说你对这篇新闻的看法...
抱歉,原内容已删除
白马非马123
2025-08-14
个人不是医药行业人士,单从我个人认知方面思考创新药发展,从开始国内的低端产业慢慢的赶超国际比如最初的鞋服,到后面的手机,到当下的汽车。都是一个从低端制造往高端制造赶超,每一次的赶超都会造就一批知名企业名利双收。我们如果想在股市赚大钱最好的方法就是找到下一个赶超的行业,在众多的行业中我觉得创新药最有潜力,买入安静的持有,静待花开。前途是光明的,道路是曲折的!
白马非马123
2025-07-10
$莱斯康制药(LXRX)$
白马非马123
2024-11-26
说说你对这篇新闻的看法...
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4090542194956520","uuid":"4090542194956520","gmtCreate":1627439295441,"gmtModify":1744048510722,"name":"白马非马123","pinyin":"bmfm123baimafeima123","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":44,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.02.10","exceedPercentage":"60.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.16","exceedPercentage":"60.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.02.10","exceedPercentage":"60.97%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"河北","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":16,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":515322457739272,"gmtCreate":1766841597456,"gmtModify":1766841599758,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090542194956520","idStr":"4090542194956520"},"themes":[],"title":"","htmlText":"这篇文章不错,转发给大家看看","listText":"这篇文章不错,转发给大家看看","text":"这篇文章不错,转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/515322457739272","repostId":"515246470631424","repostType":1,"repost":{"id":515246470631424,"gmtCreate":1766823048728,"gmtModify":1766831513837,"author":{"id":"4192713077052572","authorId":"4192713077052572","name":"等也是一种策略 如何等在哪里等","avatar":"https://static.tigerbbs.com/120755ba038fdcb70c2bb1d2816ad8f1","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4192713077052572","idStr":"4192713077052572"},"themes":[],"title":"","htmlText":"美国最大独立投行Jefferies也发了2026展望和荐股 主题是:牛市扩散与人工智能的应用阶段。荐股分4个板块: 互联网 $APP:2026年上半年广告平台大幅扩张,目标市值860亿美元 $UBER:机器人出租车合作势头向好+人口结构扩张 $SPOT:新层级业务推动利润率提升;强劲的定价能力 $RDDT:数据授权增长+用户互动加速 $ROKU:业绩反转标的;广告散射市场改善 $Z:房地产市场复苏标的;软件服务业务增长 软件 $NOW:头号标的:最“安全”的人工智能应用标的;生成式人工智能产品套件走向成熟 $SHOP:企业级应用超出预期;业绩实现增长 $TWLO:语音人工智能周期推动增长重回稳定 $HUBS:中小企业人工智能应用龙头;定价能力回归 生物科技 $DNTH:头号标的:神经肌肉疾病III期数据关键节点 $TSHA:雷特综合征基因疗法;关键监管更新 $TYRA:注射剂的口腔替代方案;同类最佳的临床数据输出 $TNG:精准肿瘤学管线走向成熟 $SLDB:杜氏肌营养不良症基因疗法更新 $ORIC:2026年上半年有望迎来肿瘤学催化剂 量子科技 $IONQ:全新赛道:纯量子算力龙头;订单积压充足 $QBTS:商用退火量子计算应用关注度提升 矿业 $FCX:铜供应紧张,满足数据中心需求增长 $GLEN:估值与同行存在偏差;资本回报故事具备吸引力 核心战略要点 1. 轮动策略:超配互联网和软件应用板块,而非纯基础设施(芯片)板块 2. 生物科技复苏:聚焦2026年有临床数据的企业 3. 量子飞跃:2026年被认定为商用量子计算的突破之年","listText":"美国最大独立投行Jefferies也发了2026展望和荐股 主题是:牛市扩散与人工智能的应用阶段。荐股分4个板块: 互联网 $APP:2026年上半年广告平台大幅扩张,目标市值860亿美元 $UBER:机器人出租车合作势头向好+人口结构扩张 $SPOT:新层级业务推动利润率提升;强劲的定价能力 $RDDT:数据授权增长+用户互动加速 $ROKU:业绩反转标的;广告散射市场改善 $Z:房地产市场复苏标的;软件服务业务增长 软件 $NOW:头号标的:最“安全”的人工智能应用标的;生成式人工智能产品套件走向成熟 $SHOP:企业级应用超出预期;业绩实现增长 $TWLO:语音人工智能周期推动增长重回稳定 $HUBS:中小企业人工智能应用龙头;定价能力回归 生物科技 $DNTH:头号标的:神经肌肉疾病III期数据关键节点 $TSHA:雷特综合征基因疗法;关键监管更新 $TYRA:注射剂的口腔替代方案;同类最佳的临床数据输出 $TNG:精准肿瘤学管线走向成熟 $SLDB:杜氏肌营养不良症基因疗法更新 $ORIC:2026年上半年有望迎来肿瘤学催化剂 量子科技 $IONQ:全新赛道:纯量子算力龙头;订单积压充足 $QBTS:商用退火量子计算应用关注度提升 矿业 $FCX:铜供应紧张,满足数据中心需求增长 $GLEN:估值与同行存在偏差;资本回报故事具备吸引力 核心战略要点 1. 轮动策略:超配互联网和软件应用板块,而非纯基础设施(芯片)板块 2. 生物科技复苏:聚焦2026年有临床数据的企业 3. 量子飞跃:2026年被认定为商用量子计算的突破之年","text":"美国最大独立投行Jefferies也发了2026展望和荐股 主题是:牛市扩散与人工智能的应用阶段。荐股分4个板块: 互联网 $APP:2026年上半年广告平台大幅扩张,目标市值860亿美元 $UBER:机器人出租车合作势头向好+人口结构扩张 $SPOT:新层级业务推动利润率提升;强劲的定价能力 $RDDT:数据授权增长+用户互动加速 $ROKU:业绩反转标的;广告散射市场改善 $Z:房地产市场复苏标的;软件服务业务增长 软件 $NOW:头号标的:最“安全”的人工智能应用标的;生成式人工智能产品套件走向成熟 $SHOP:企业级应用超出预期;业绩实现增长 $TWLO:语音人工智能周期推动增长重回稳定 $HUBS:中小企业人工智能应用龙头;定价能力回归 生物科技 $DNTH:头号标的:神经肌肉疾病III期数据关键节点 $TSHA:雷特综合征基因疗法;关键监管更新 $TYRA:注射剂的口腔替代方案;同类最佳的临床数据输出 $TNG:精准肿瘤学管线走向成熟 $SLDB:杜氏肌营养不良症基因疗法更新 $ORIC:2026年上半年有望迎来肿瘤学催化剂 量子科技 $IONQ:全新赛道:纯量子算力龙头;订单积压充足 $QBTS:商用退火量子计算应用关注度提升 矿业 $FCX:铜供应紧张,满足数据中心需求增长 $GLEN:估值与同行存在偏差;资本回报故事具备吸引力 核心战略要点 1. 轮动策略:超配互联网和软件应用板块,而非纯基础设施(芯片)板块 2. 生物科技复苏:聚焦2026年有临床数据的企业 3. 量子飞跃:2026年被认定为商用量子计算的突破之年","images":[{"img":"https://static.tigerbbs.com/6a47ccd9043726d781296fe749eebe8c","width":"1024","height":"559"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/515246470631424","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":509542769311944,"gmtCreate":1765438029109,"gmtModify":1765438031517,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090542194956520","idStr":"4090542194956520"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02171\">$科济药业-B(02171)$</a> ","listText":"<a href=\"https://laohu8.com/S/02171\">$科济药业-B(02171)$</a> ","text":"$科济药业-B(02171)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/509542769311944","isVote":1,"tweetType":1,"viewCount":813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":508116253356992,"gmtCreate":1765082494938,"gmtModify":1765082500414,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090542194956520","idStr":"4090542194956520"},"themes":[],"htmlText":"本来很早很早就下载了老虎,但一直没有迈开第一步,直到2025走出了第一步,今年的收入大概百分之八十,边做边学习,我是那种喜欢买了就不急长期拿着的,曾经在大一次一次让我失望。在这里终于找到了适合我的操作方式的市场,很感恩老虎,让我明白平台的重要性。对于2026年我的期望是有百分之十就可以,拿好自己看好的公司。祝大家新的一年都好运连连,也祝老虎越办越好。","listText":"本来很早很早就下载了老虎,但一直没有迈开第一步,直到2025走出了第一步,今年的收入大概百分之八十,边做边学习,我是那种喜欢买了就不急长期拿着的,曾经在大一次一次让我失望。在这里终于找到了适合我的操作方式的市场,很感恩老虎,让我明白平台的重要性。对于2026年我的期望是有百分之十就可以,拿好自己看好的公司。祝大家新的一年都好运连连,也祝老虎越办越好。","text":"本来很早很早就下载了老虎,但一直没有迈开第一步,直到2025走出了第一步,今年的收入大概百分之八十,边做边学习,我是那种喜欢买了就不急长期拿着的,曾经在大一次一次让我失望。在这里终于找到了适合我的操作方式的市场,很感恩老虎,让我明白平台的重要性。对于2026年我的期望是有百分之十就可以,拿好自己看好的公司。祝大家新的一年都好运连连,也祝老虎越办越好。","images":[{"img":"https://static.tigerbbs.com/65db1a8fa77455c10f025c89a015dc2b"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/508116253356992","isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":486656056606880,"gmtCreate":1759841228830,"gmtModify":1759842992916,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090542194956520","idStr":"4090542194956520"},"themes":[],"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/486656056606880","repostId":"2573644155","repostType":2,"isVote":1,"tweetType":1,"viewCount":975,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":467575496753504,"gmtCreate":1755171026158,"gmtModify":1755177249014,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090542194956520","idStr":"4090542194956520"},"themes":[],"htmlText":"个人不是医药行业人士,单从我个人认知方面思考创新药发展,从开始国内的低端产业慢慢的赶超国际比如最初的鞋服,到后面的手机,到当下的汽车。都是一个从低端制造往高端制造赶超,每一次的赶超都会造就一批知名企业名利双收。我们如果想在股市赚大钱最好的方法就是找到下一个赶超的行业,在众多的行业中我觉得创新药最有潜力,买入安静的持有,静待花开。前途是光明的,道路是曲折的!","listText":"个人不是医药行业人士,单从我个人认知方面思考创新药发展,从开始国内的低端产业慢慢的赶超国际比如最初的鞋服,到后面的手机,到当下的汽车。都是一个从低端制造往高端制造赶超,每一次的赶超都会造就一批知名企业名利双收。我们如果想在股市赚大钱最好的方法就是找到下一个赶超的行业,在众多的行业中我觉得创新药最有潜力,买入安静的持有,静待花开。前途是光明的,道路是曲折的!","text":"个人不是医药行业人士,单从我个人认知方面思考创新药发展,从开始国内的低端产业慢慢的赶超国际比如最初的鞋服,到后面的手机,到当下的汽车。都是一个从低端制造往高端制造赶超,每一次的赶超都会造就一批知名企业名利双收。我们如果想在股市赚大钱最好的方法就是找到下一个赶超的行业,在众多的行业中我觉得创新药最有潜力,买入安静的持有,静待花开。前途是光明的,道路是曲折的!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/467575496753504","isVote":1,"tweetType":1,"viewCount":2090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":455141526909024,"gmtCreate":1752155792370,"gmtModify":1752158077024,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090542194956520","idStr":"4090542194956520"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LXRX\">$莱斯康制药(LXRX)$</a> ","listText":"<a href=\"https://laohu8.com/S/LXRX\">$莱斯康制药(LXRX)$</a> ","text":"$莱斯康制药(LXRX)$","images":[{"img":"https://static.tigerbbs.com/dc8d0afd9f7942db1749eaee30044afd","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/455141526909024","isVote":1,"tweetType":1,"viewCount":1813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":375160802943256,"gmtCreate":1732634187394,"gmtModify":1732634421276,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090542194956520","idStr":"4090542194956520"},"themes":[],"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/375160802943256","repostId":"1178300881","repostType":2,"isVote":1,"tweetType":1,"viewCount":2240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":455141526909024,"gmtCreate":1752155792370,"gmtModify":1752158077024,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090542194956520","authorIdStr":"4090542194956520"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LXRX\">$莱斯康制药(LXRX)$</a> ","listText":"<a href=\"https://laohu8.com/S/LXRX\">$莱斯康制药(LXRX)$</a> ","text":"$莱斯康制药(LXRX)$","images":[{"img":"https://static.tigerbbs.com/dc8d0afd9f7942db1749eaee30044afd","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/455141526909024","isVote":1,"tweetType":1,"viewCount":1813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":515322457739272,"gmtCreate":1766841597456,"gmtModify":1766841599758,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090542194956520","authorIdStr":"4090542194956520"},"themes":[],"title":"","htmlText":"这篇文章不错,转发给大家看看","listText":"这篇文章不错,转发给大家看看","text":"这篇文章不错,转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/515322457739272","repostId":"515246470631424","repostType":1,"repost":{"id":515246470631424,"gmtCreate":1766823048728,"gmtModify":1766831513837,"author":{"id":"4192713077052572","authorId":"4192713077052572","name":"等也是一种策略 如何等在哪里等","avatar":"https://static.tigerbbs.com/120755ba038fdcb70c2bb1d2816ad8f1","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4192713077052572","authorIdStr":"4192713077052572"},"themes":[],"title":"","htmlText":"美国最大独立投行Jefferies也发了2026展望和荐股 主题是:牛市扩散与人工智能的应用阶段。荐股分4个板块: 互联网 $APP:2026年上半年广告平台大幅扩张,目标市值860亿美元 $UBER:机器人出租车合作势头向好+人口结构扩张 $SPOT:新层级业务推动利润率提升;强劲的定价能力 $RDDT:数据授权增长+用户互动加速 $ROKU:业绩反转标的;广告散射市场改善 $Z:房地产市场复苏标的;软件服务业务增长 软件 $NOW:头号标的:最“安全”的人工智能应用标的;生成式人工智能产品套件走向成熟 $SHOP:企业级应用超出预期;业绩实现增长 $TWLO:语音人工智能周期推动增长重回稳定 $HUBS:中小企业人工智能应用龙头;定价能力回归 生物科技 $DNTH:头号标的:神经肌肉疾病III期数据关键节点 $TSHA:雷特综合征基因疗法;关键监管更新 $TYRA:注射剂的口腔替代方案;同类最佳的临床数据输出 $TNG:精准肿瘤学管线走向成熟 $SLDB:杜氏肌营养不良症基因疗法更新 $ORIC:2026年上半年有望迎来肿瘤学催化剂 量子科技 $IONQ:全新赛道:纯量子算力龙头;订单积压充足 $QBTS:商用退火量子计算应用关注度提升 矿业 $FCX:铜供应紧张,满足数据中心需求增长 $GLEN:估值与同行存在偏差;资本回报故事具备吸引力 核心战略要点 1. 轮动策略:超配互联网和软件应用板块,而非纯基础设施(芯片)板块 2. 生物科技复苏:聚焦2026年有临床数据的企业 3. 量子飞跃:2026年被认定为商用量子计算的突破之年","listText":"美国最大独立投行Jefferies也发了2026展望和荐股 主题是:牛市扩散与人工智能的应用阶段。荐股分4个板块: 互联网 $APP:2026年上半年广告平台大幅扩张,目标市值860亿美元 $UBER:机器人出租车合作势头向好+人口结构扩张 $SPOT:新层级业务推动利润率提升;强劲的定价能力 $RDDT:数据授权增长+用户互动加速 $ROKU:业绩反转标的;广告散射市场改善 $Z:房地产市场复苏标的;软件服务业务增长 软件 $NOW:头号标的:最“安全”的人工智能应用标的;生成式人工智能产品套件走向成熟 $SHOP:企业级应用超出预期;业绩实现增长 $TWLO:语音人工智能周期推动增长重回稳定 $HUBS:中小企业人工智能应用龙头;定价能力回归 生物科技 $DNTH:头号标的:神经肌肉疾病III期数据关键节点 $TSHA:雷特综合征基因疗法;关键监管更新 $TYRA:注射剂的口腔替代方案;同类最佳的临床数据输出 $TNG:精准肿瘤学管线走向成熟 $SLDB:杜氏肌营养不良症基因疗法更新 $ORIC:2026年上半年有望迎来肿瘤学催化剂 量子科技 $IONQ:全新赛道:纯量子算力龙头;订单积压充足 $QBTS:商用退火量子计算应用关注度提升 矿业 $FCX:铜供应紧张,满足数据中心需求增长 $GLEN:估值与同行存在偏差;资本回报故事具备吸引力 核心战略要点 1. 轮动策略:超配互联网和软件应用板块,而非纯基础设施(芯片)板块 2. 生物科技复苏:聚焦2026年有临床数据的企业 3. 量子飞跃:2026年被认定为商用量子计算的突破之年","text":"美国最大独立投行Jefferies也发了2026展望和荐股 主题是:牛市扩散与人工智能的应用阶段。荐股分4个板块: 互联网 $APP:2026年上半年广告平台大幅扩张,目标市值860亿美元 $UBER:机器人出租车合作势头向好+人口结构扩张 $SPOT:新层级业务推动利润率提升;强劲的定价能力 $RDDT:数据授权增长+用户互动加速 $ROKU:业绩反转标的;广告散射市场改善 $Z:房地产市场复苏标的;软件服务业务增长 软件 $NOW:头号标的:最“安全”的人工智能应用标的;生成式人工智能产品套件走向成熟 $SHOP:企业级应用超出预期;业绩实现增长 $TWLO:语音人工智能周期推动增长重回稳定 $HUBS:中小企业人工智能应用龙头;定价能力回归 生物科技 $DNTH:头号标的:神经肌肉疾病III期数据关键节点 $TSHA:雷特综合征基因疗法;关键监管更新 $TYRA:注射剂的口腔替代方案;同类最佳的临床数据输出 $TNG:精准肿瘤学管线走向成熟 $SLDB:杜氏肌营养不良症基因疗法更新 $ORIC:2026年上半年有望迎来肿瘤学催化剂 量子科技 $IONQ:全新赛道:纯量子算力龙头;订单积压充足 $QBTS:商用退火量子计算应用关注度提升 矿业 $FCX:铜供应紧张,满足数据中心需求增长 $GLEN:估值与同行存在偏差;资本回报故事具备吸引力 核心战略要点 1. 轮动策略:超配互联网和软件应用板块,而非纯基础设施(芯片)板块 2. 生物科技复苏:聚焦2026年有临床数据的企业 3. 量子飞跃:2026年被认定为商用量子计算的突破之年","images":[{"img":"https://static.tigerbbs.com/6a47ccd9043726d781296fe749eebe8c","width":"1024","height":"559"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/515246470631424","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":509542769311944,"gmtCreate":1765438029109,"gmtModify":1765438031517,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090542194956520","authorIdStr":"4090542194956520"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02171\">$科济药业-B(02171)$</a> ","listText":"<a href=\"https://laohu8.com/S/02171\">$科济药业-B(02171)$</a> ","text":"$科济药业-B(02171)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/509542769311944","isVote":1,"tweetType":1,"viewCount":813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":508116253356992,"gmtCreate":1765082494938,"gmtModify":1765082500414,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090542194956520","authorIdStr":"4090542194956520"},"themes":[],"htmlText":"本来很早很早就下载了老虎,但一直没有迈开第一步,直到2025走出了第一步,今年的收入大概百分之八十,边做边学习,我是那种喜欢买了就不急长期拿着的,曾经在大一次一次让我失望。在这里终于找到了适合我的操作方式的市场,很感恩老虎,让我明白平台的重要性。对于2026年我的期望是有百分之十就可以,拿好自己看好的公司。祝大家新的一年都好运连连,也祝老虎越办越好。","listText":"本来很早很早就下载了老虎,但一直没有迈开第一步,直到2025走出了第一步,今年的收入大概百分之八十,边做边学习,我是那种喜欢买了就不急长期拿着的,曾经在大一次一次让我失望。在这里终于找到了适合我的操作方式的市场,很感恩老虎,让我明白平台的重要性。对于2026年我的期望是有百分之十就可以,拿好自己看好的公司。祝大家新的一年都好运连连,也祝老虎越办越好。","text":"本来很早很早就下载了老虎,但一直没有迈开第一步,直到2025走出了第一步,今年的收入大概百分之八十,边做边学习,我是那种喜欢买了就不急长期拿着的,曾经在大一次一次让我失望。在这里终于找到了适合我的操作方式的市场,很感恩老虎,让我明白平台的重要性。对于2026年我的期望是有百分之十就可以,拿好自己看好的公司。祝大家新的一年都好运连连,也祝老虎越办越好。","images":[{"img":"https://static.tigerbbs.com/65db1a8fa77455c10f025c89a015dc2b"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/508116253356992","isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":486656056606880,"gmtCreate":1759841228830,"gmtModify":1759842992916,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090542194956520","authorIdStr":"4090542194956520"},"themes":[],"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/486656056606880","repostId":"2573644155","repostType":2,"isVote":1,"tweetType":1,"viewCount":975,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":467575496753504,"gmtCreate":1755171026158,"gmtModify":1755177249014,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090542194956520","authorIdStr":"4090542194956520"},"themes":[],"htmlText":"个人不是医药行业人士,单从我个人认知方面思考创新药发展,从开始国内的低端产业慢慢的赶超国际比如最初的鞋服,到后面的手机,到当下的汽车。都是一个从低端制造往高端制造赶超,每一次的赶超都会造就一批知名企业名利双收。我们如果想在股市赚大钱最好的方法就是找到下一个赶超的行业,在众多的行业中我觉得创新药最有潜力,买入安静的持有,静待花开。前途是光明的,道路是曲折的!","listText":"个人不是医药行业人士,单从我个人认知方面思考创新药发展,从开始国内的低端产业慢慢的赶超国际比如最初的鞋服,到后面的手机,到当下的汽车。都是一个从低端制造往高端制造赶超,每一次的赶超都会造就一批知名企业名利双收。我们如果想在股市赚大钱最好的方法就是找到下一个赶超的行业,在众多的行业中我觉得创新药最有潜力,买入安静的持有,静待花开。前途是光明的,道路是曲折的!","text":"个人不是医药行业人士,单从我个人认知方面思考创新药发展,从开始国内的低端产业慢慢的赶超国际比如最初的鞋服,到后面的手机,到当下的汽车。都是一个从低端制造往高端制造赶超,每一次的赶超都会造就一批知名企业名利双收。我们如果想在股市赚大钱最好的方法就是找到下一个赶超的行业,在众多的行业中我觉得创新药最有潜力,买入安静的持有,静待花开。前途是光明的,道路是曲折的!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/467575496753504","isVote":1,"tweetType":1,"viewCount":2090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":375160802943256,"gmtCreate":1732634187394,"gmtModify":1732634421276,"author":{"id":"4090542194956520","authorId":"4090542194956520","name":"白马非马123","avatar":"https://static.tigerbbs.com/395ddb5d41bef038bf6c31fd6f8636ee","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090542194956520","authorIdStr":"4090542194956520"},"themes":[],"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/375160802943256","repostId":"1178300881","repostType":2,"isVote":1,"tweetType":1,"viewCount":2240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}